Does COVID-19 increase the long-term relapsing-remitting multiple sclerosis clinical activity? A cohort study.

BMC Neurol · 2022 · PMC8861623 · PMID 35193507

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

This decrease did not reach statistical significance in the sensitivity analysis, and remains to be confirmed in replicative studies, however, we confirmed that the cumulative PDP rates are, at least, unlikely to be increased long after recovering from COVID-19.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.